Epidemiological profile and north–south gradient driving baseline systemic involvement of primary Sjögren’s syndrome
- 24 December 2019
- journal article
- research article
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 59 (9), 2350-2359
- https://doi.org/10.1093/rheumatology/kez578
Abstract
Objective To characterize the systemic phenotype of primary Sjögren’s syndrome at diagnosis by analysing the EULAR-SS disease activity index (ESSDAI) scores. Methods The Sjögren Big Data Consortium is an international, multicentre registry based on worldwide data-sharing cooperative merging of pre-existing databases from leading centres in clinical research in Sjögren’s syndrome from the five continents. Results The cohort included 10 007 patients (9352 female, mean 53 years) with recorded ESSDAI scores available. At diagnosis, the mean total ESSDAI score was 6.1; 81.8% of patients had systemic activity (ESSDAI score ≥1). Males had a higher mean ESSDAI (8.1 vs 6.0, P < 0.001) compared with females, as did patients diagnosed at 65 years, P < 0.001). The highest global ESSDAI score was reported in Black/African Americans, followed by White, Asian and Hispanic patients (6.7, 6.5, 5.4 and 4.8, respectively; P < 0.001). The frequency of involvement of each systemic organ also differed between ethnic groups, with Black/African American patients showing the highest frequencies in the lymphadenopathy, articular, peripheral nervous system, CNS and biological domains, White patients in the glandular, cutaneous and muscular domains, Asian patients in the pulmonary, renal and haematological domains and Hispanic patients in the constitutional domain. Systemic activity measured by the ESSDAI, clinical ESSDAI (clinESSDAI) and disease activity states was higher in patients from southern countries (P < 0.001). Conclusion The systemic phenotype of primary Sjögren’s syndrome is strongly influenced by personal determinants such as age, gender, ethnicity and place of residence, which are key geoepidemiological players in driving the expression of systemic disease at diagnosis.Funding Information
- Fondo de Investigaciones Sanitarias (INT15/00085)
- Hospital Clinic Barcelona
This publication has 49 references indexed in Scilit:
- Epidemiology of Primary Sjögren's Syndrome in a French Multiracial/Multiethnic AreaArthritis Care & Research, 2013
- Serum Levels of Beta2-Microglobulin and Free Light Chains of Immunoglobulins Are Associated with Systemic Disease Activity in Primary Sjögren’s Syndrome. Data at Enrollment in the Prospective ASSESS CohortPLOS ONE, 2013
- Geoepidemiology of autoimmune rheumatic diseasesNature Reviews Rheumatology, 2010
- Defining and analyzing geoepidemiology and human autoimmunityJournal of Autoimmunity, 2010
- The geoepidemiology of autoimmune intestinal diseasesAutoimmunity Reviews, 2010
- Primary Sjogren's syndrome: too dry and too tiredRheumatology, 2010
- EULAR Sjögren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjögren's syndromeAnnals Of The Rheumatic Diseases, 2009
- What have we learned from a 10-year experience with the lumina (Lupus in Minorities; Nature vs. nurture) cohort? Where are we heading?Autoimmunity Reviews, 2004
- Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus GroupAnnals Of The Rheumatic Diseases, 2002
- Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European communityArthritis & Rheumatism, 1993